Category: PAD

Femoropopliteal bypass shows reintervention benefit over endovascular therapy for advanced premature PAD

Femoropopliteal bypass is associated with decreased reinterventions at one year compared to endovascular therapy in patients with advanced premature peripheral arterial disease (PAD). This is the primary conclusion of Tanner I Kim (Yale School of Medicine, New Haven, USA) and colleagues, writing in an article recently published online in the Journal of Vascular Surgery. The […]

The post Femoropopliteal bypass shows reintervention benefit over endovascular therapy for advanced premature PAD appeared first on Vascular News.

ACC 2021: VOYAGER-PAD analysis shows totality of ischaemic events reduced following rivaroxaban use

Rupert Bauersachs (Darmstadt, Germany) talks to Cardiovascular News about the VOYAGER-PAD trial, the results of which he presented at the American College of Cardiology’s 70th Annual Scientific Session (ACC.21, 15–17 May, virtual) and which highlighted a reduced risk of ischaemic events in peripheral artierial disease (PAD) patients receiving rivaroxaban. The analysis, presented by Bauersachs, focused […]

The post ACC 2021: VOYAGER-PAD analysis shows totality of ischaemic events reduced following rivaroxaban use appeared first on Vascular News.